Pancreatic Function Study in Early Type 2 Diabetes
Part of Bones, joints & muscles, Digestive system, Genetic & congenital, Hormones & metabolism clinical trials.
This study examines how the pancreas works in people newly diagnosed with type 2 diabetes. Researchers will assess pancreatic function to better understand early diabetes and potentially improve treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18–74 years old and of Kazakh nationality
- You have been diagnosed with type 2 diabetes (not type 1) within the last 5 years
- You have not had diabetic ketoacidosis (a serious blood sugar emergency) in the past 6 months
- You do not have cancer or a history of cancer
- You are not pregnant, breastfeeding, or planning to become pregnant
- You do not have severe liver disease, autoimmune disease, or other serious chronic conditions
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how the pancreas affects blood sugar and diabetes. It may help find better ways to prevent or treat type 2 diabetes.
This study examines how insulin-producing cells (beta cells) function in people diagnosed with type 2 diabetes before age 40. Understanding these differences may help doctors develop better treatments for younger patients.
This trial looks at how certain cells in the pancreas work in people newly diagnosed with type 2 diabetes. It may help doctors understand the disease better and find new treatment approaches.
This is a screening study to identify and understand people with type 2 diabetes whose blood sugar isn't well controlled, so they can potentially join future diabetes research trials. You won't receive a new treatment in this study—it's about getting to know your health history and seeing if you might be a good fit for upcoming studies.
This trial tests how two diabetes medications, SGLT2i and pioglitazone, affect ketone production in people with type 1 diabetes. It aims to find new ways to improve blood sugar control.
This study looks at people recently diagnosed with type 2 diabetes to check their pancreas health using blood tests and scans. The goal is to find early signs of pancreatic issues, which might help catch problems sooner.
Hear when a new Pancreatogenic Diabetes Mellitus trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.